期刊文献+

基于Topomer CoMFA方法的喹诺酮羧酸类衍生物的QSAR研究及分子设计 被引量:5

QSAR Study and Molecular Design of Quinonlone Carboxylic Acid Derivatives Based on Topomer CoMFA Method
下载PDF
导出
摘要 采用基于R基团搜索技术的Topomer Co MFA技术对一系列喹诺酮羧酸类衍生物进行三维定量构效(3D-QSAR)关系研究,所得模型结果的交叉验证相关系数(q2)为0.790,非交互验证系数(r2)为0.890,外部验证的复相关系数(r2pred)为0.878,研究结果表明该模型具有良好的稳定性和预测能力。采用Topomer search技术在ZINC数据库中进行虚拟筛选,筛选出6个Ra基团和3个Rb基团,进而设计出12个具有更高活性的新型喹诺酮羧酸类化合物。采用分子对接技术对药物与受体的作用机制进行了研究,结果显示,药物与蛋白酶的ASP 30、ASP 29和ASN 25位点作用明显,该QSAR的研究结果可为新药合成提供理论参考。 The 3 D-QSAR relationships of a series of quinolone carboxylic acid derivatives were studied by Topomer Co MFA technique based on R group search. The interaction validation coefficient(q2),the non-cross correlation coefficient(r^2) and the external validation coefficiont(rpred^2) were0. 790,0. 890 and 0. 878,respectively. The results showed that the model had a good stability and a prediction ability. Topomer search was used to virtually screen lead-like compounds in the ZINC molecular database. As a result,6 Ra groups and 3 Rb groups with higher contribution values were selected. 12 new quinolone carboxylic acid compounds with higher predicted activity were designed.By using molecular docking,the action mechanism of drug and acceptor was studied,and the results showed that the drug functioned obviously with ASP 30,ASP 29 and ASN 25 sites of protease. The QSAR study could provide a theoretical reference for the synthesis of new drugs.
作者 仝建波 雷珊 秦尚尚 王洋 TONG Jian-bo;LEI Shan;QIN Shang-shang;WANG Yang(College of Chemistry & Chemical Engineering,Shaanxi University of Science & Technology,Xi’an 710021,China;Key Laboratory of Auxiliary Chemistry & Technology for Chemical Industry,Ministryof Education,Shaanxi University of Science & Technology,Xi’an 710021,China)
出处 《分析测试学报》 CAS CSCD 北大核心 2018年第5期517-524,共8页 Journal of Instrumental Analysis
基金 国家自然科学基金(21475081) 陕西省自然科学基础研究计划(2015JM2057) 陕西科技大学研究生创新基金
关键词 三维定量构效(3D-QSAR) 喹诺酮羧酸类衍生物 Topomer COMFA 分子设计 分子对接 three-dimensional quantitative structure - activity relationship(3D -QSAR) quinolone carboxylic acid derivatives Topomer CoMFA molecular design molecular docking
  • 相关文献

参考文献10

二级参考文献97

  • 1刘明亮.喹诺酮类抗菌药在不同介质中的理化性质[J].国外医药(抗生素分册),2006,27(1):22-34. 被引量:9
  • 2陈清西,林建峰,宋康康.酪氨酸酶抑制剂的研究进展[J].厦门大学学报(自然科学版),2007,46(2):274-282. 被引量:75
  • 3Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet, 2006, 368: 387-403.
  • 4Citron M. Alzheimer's disease: Strategies for disease modification. Nat Rev Drug Discov, 2010, 9: 387-398.
  • 5Mandelkow E. Alzheimer's disease. The tangled tale of tau. Nature, 1999, 402: 588-589.
  • 6Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science, 1990, 248: 1122-1124.
  • 7Golde TE, Petrucelli L, Lewis J. Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp Neurol, 2010, 223: 252-266.
  • 8Gong CX, Liu F, Grundke-Iqbal I, Iqbal K. Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm, 2005, 112: 813-838.
  • 9Tanimukai H, Grundke-Iqbal I, Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol, 2005, 166: 1761-1771.
  • 10Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev, 2000, 33: 95-130.

共引文献31

同被引文献44

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部